DESCRIPTION:
Data suggest that Bitter Melon has a significant
hypoglycemic effect occurs in both healthy and diabetic
patients. Glucose control contains well known botanical
ingredient Mormodica Charantia otherwise known as Bitter Melon.
Mormodica Charantia (Bitter Melon) contains Glycosides,
Momordim, Charantin, Polypeptides. Bitter Melon increases
glucose uptake and glycogen synthesis in the liver, muscle and
nerve tissue and improves glucose tolerance. Bitter Melon,
grouped with Fenugreek (another hypoglycemic herb), in
conjunction with Curcuma Zodoria helps liver cells respond
quickly, and improves liver function.
* Helps build
strong immune system
* Helps build glucose tolerance
*
Helps maintain proper blood sugar levels
* Helps regulate
lipid metabolism and maintain healthy cholesterol levels
*
Helps maintain healthy serum triglyceride levels
* Helps
maintain good health
BITTER MELON
A prospective evaluation
of 18 newly diagnosed adult diabetics comparing blood glucose
level with and without bitter melon administration 30 minutes
prior to an oral glucose tolerance test (GTT). Patients had not
started any hypoglycemic therapy (e.g. insulin or
sulfonylureas). A statistically significant reduction in blood
sugar after administration of bitter melon, approximately
20-30%, was demonstrated. Larger randomized trials are necessary
to establish long-term effects.
FENUGREEK
A prospective,
one-arm study of dietary fenugreek in 60 patients with
non-insulin dependent diabetes of differing severity levels. 40
patients were taking oral hypoglycemic drugs. Each subject
underwent 7 days of control diet followed by 24 weeks of
consuming 25 g/day fenugreek seed powder prepared in a soup.
Diets in each period were similar in calorie and nutrient
composition, except for higher fiber content in the fenugreek
diet. Mean serum cholesterol decreased from baseline (approx.
241 mg/dl) to 24 weeks (approx. 199 mg/dl), as did LDL
cholesterol (approx. 143 to 114 mg/dl), LDL+VLDL cholesterol
(approx. 179 to 148 mg/dl), and triglycerides (approx. 187 to
159 mg/dl). Diarrhea and flatulence were reported in a few
patients.
A randomized, controlled, crossover evaluation of
dietary fenugreek in 10 non-insulin dependent diabetics taking
glibenclamide, 2.5-7.5 mg/day, with stabilized diet and drug
dose. The study consisted of two 15-day periods: 5 patients
received bread containing 25 g fenugreek powder daily for the
first 15 days, while the other 5 received it in the second
15-day period. Control bread contained the same nutrient content
without fenugreek. Food intake and body weight were similar
between treatment arms. An intravenous glucose tolerance test at
the end of each period showed significantly lower mean plasma
glucose levels at 40, 50, and 60 min and an 11% reduction in the
area under the curve (AUC) in the fenugreek group. Erythrocyte
insulin receptors were significantly higher in number in the
fenugreek group. A washout period should have been instituted
between test periods.
DOSAGE:Two capsules twice daily before
food
|
